ARCHIVES

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

This article is from The Cancer Letter archive.

Vol. 19 No. 34 | September 3, 1993

Download PDF Visit The Full Archive

Related Articles

In Brief: Norman Sharpless Named Director of UNC Lineberger

September 6, 2013

Interactive R01 Scores Vary widely, Result Of separate Review

June 11, 1993

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

July 26, 2013

President Signs Interim Money Bill; NCI At $725 Million

July 4, 1975

NIH Returns to Play Catch Up “After 16 Costly, Wasteful Days”

October 18, 2013

In Brief: HHS Names Deputy HCFA Administrator; M.D. Anderson’s Error-Free Record Honored

July 4, 1997